Verrica Pharmaceuticals Inc.
VRCA
$0.4891
$0.02264.85%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -16.20M | -22.86M | -17.19M | -20.33M | -24.61M |
| Total Depreciation and Amortization | 253.00K | 342.00K | 334.00K | 340.00K | 217.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.98M | 2.94M | 2.89M | 2.56M | 5.02M |
| Change in Net Operating Assets | -4.09M | 11.02M | -2.39M | -2.51M | 4.87M |
| Cash from Operations | -16.06M | -8.56M | -16.36M | -19.95M | -14.51M |
| Capital Expenditure | 0.00 | -16.00K | -11.00K | -- | -227.00K |
| Sale of Property, Plant, and Equipment | 8.00K | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 8.00K | -16.00K | -11.00K | -- | -227.00K |
| Total Debt Issued | -- | -- | -- | -- | 0.00 |
| Total Debt Repaid | -374.00K | -217.00K | -177.00K | -156.00K | -23.00K |
| Issuance of Common Stock | 39.64M | 0.00 | 150.00K | 4.00K | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -1.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 162.00K | -180.00K | -613.00K | -509.00K | -3.00K |
| Cash from Financing | 39.43M | -397.00K | -640.00K | -661.00K | -27.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 23.37M | -8.97M | -17.01M | -20.61M | -14.76M |